The international professional excellence awards is held by the Eurasian Academy of Good Practices and Russia's Ministry of Industry and Trade with the support of the Eurasian Economic Commission. This year's GxP-Profi coincides with the fiftieth anniversary of the State Institute of Drugs and Good Practices of Russia's Ministry of Industry and Trade. The institute's goal is to ensure compliance with the GMP guidelines. This resonates with the main objective of the awards, i.e. fostering the industry’s potential by developing and implementing innovations in order to improve quality in pharmaceutical manufacturing.

The goals of the 2023 GxP-Profi include identifying the leading EAEU pharmaceutical manufacturers in terms of quality assurance, promoting the best innovative solutions in the industry, enhancing the image of the EAEU pharma companies, and boosting their competitive advantage in the global market.

The award is open to successfully implemented innovative solutions designed to improve the quality system in pharmaceutical manufacturing. Each entry is judged based on the following criteria: how relevant the project is for quality assurance in pharma manufacturing, how innovative the solution is, whether it has been implemented at the production site with proven success, and whether it can be discussed publicly. Projects are reviewed by an independent expert committee featuring representatives of Russia’s Ministry of Industry and Trade, as well as Russia’s and the world’s leading industry experts.

The 2023 qualification round will be conducted remotely from 1 July to 15 October. The results will be shared on 27 October.

The finals will be held as a hybrid event in November 2023. The winners will be decided on the basis of their presentation and discussion of the project. The award ceremony will take place in early December at an official meeting of industry leaders, where the heads of Russia’s Ministry of Industry and Trade will honor the winning companies’ directors with the prestigious GxP-Profi award.

Last year, a total of over 20 entries were submitted by participants from Russia, the EAEU and other countries. Of these, the 2022 GxP-Profi expert committee selected 10 best projects. Companies such as Akrikhin, Biocad, Valenta Pharm, Geropharm, Minskintercaps, Polysan, Sotex, R-Pharm, and Pharmasyntez all made it to the finals. The first prize was awarded to Akrikhin's Data Integrity. From Good to the Best! project. R-Pharm's Automation of Pharma Quality System Management came second, followed by Pharmasyntez's Utilities & Solutions for Manufacturing Hazardous Drugs in Compliance with the Current Regulations. The projects presented to the public at Pharmtech&Ingredients, the largest industry fair in Russia and the EAEU, created a real sensation.

Faiza Yagudina, Quality Director at Akrikhin, considers GxP-Profi as a great challenge both for her project team and for the entire industry. 'First and foremost, GxP-Profi has helped us once again to reveal our potential and to bring about results. All in all, it has demonstrated what we are capable of', pointed out Faiza Yagudina.

According to Tatyana Vyazmina, R-Pharm's Quality Director, GxP-Profi has a particular importance for the industry as a whole because it enables all the Eurasian states to share their experience.

Valery Aristov, Pharmasyntez's Corporate Quality Director, believes that GxP-Profi, as a showcase of the most promising and effective innovations, helps to make pharmaceuticals safer and more accessible for consumers. 'This useful and exciting event will allow us to optimize the industry's key business processes, and to phase out inefficient solutions', said Valery Aristov.

The 2023 edition of GxP-Profi promises to be an even bigger event. It is expected to attract a greater number of participants and to draw more attention from both the professional community and the general public. GxP-Profi is a chance to showcase your achievements, to claim authorship of your innovations and their affiliation with your company, to get an independent expert review, to gain public recognition, and to enter to win a prestigious industry award. Your expertise in running a company dedicated to innovation in quality assurance will receive extended coverage in the professional community and the media. The organizers are planning a full-fledged PR campaign, with the finalists’ projects presented at the 2023 Pharmtech&Ingredients fair.

Competition Regulations: watch here
Instructions for registration of participants «GxP-Profi»: watch here